Compare OI & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OI | ITGR |
|---|---|---|
| Founded | 1903 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | N/A | 2000 |
| Metric | OI | ITGR |
|---|---|---|
| Price | $16.45 | $85.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $17.43 | ★ $86.67 |
| AVG Volume (30 Days) | ★ 1.5M | 556.4K |
| Earning Date | 02-10-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.42 |
| Revenue | ★ $6,455,000,000.00 | $1,831,074,000.00 |
| Revenue This Year | $1.39 | $9.58 |
| Revenue Next Year | $1.43 | N/A |
| P/E Ratio | ★ N/A | $35.15 |
| Revenue Growth | N/A | ★ 9.54 |
| 52 Week Low | $9.23 | $62.00 |
| 52 Week High | $16.69 | $144.76 |
| Indicator | OI | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 61.15 |
| Support Level | $14.91 | $85.11 |
| Resistance Level | $16.69 | $87.21 |
| Average True Range (ATR) | 0.45 | 1.99 |
| MACD | 0.09 | -0.40 |
| Stochastic Oscillator | 92.93 | 63.80 |
O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.